Nkarta, Inc. (NKTX)
NASDAQ: NKTX · IEX Real-Time Price · USD
6.21
-0.44 (-6.62%)
At close: Jul 19, 2024, 4:00 PM
6.23
+0.02 (0.32%)
Pre-market: Jul 22, 2024, 8:05 AM EDT
Nkarta Employees
Nkarta had 150 employees as of December 31, 2023. The number of employees decreased by 13 or -7.98% compared to the previous year.
Employees
150
Change (1Y)
-13
Growth (1Y)
-7.98%
Revenue / Employee
n/a
Profits / Employee
-$774,693
Market Cap
437.60M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 150 | -13 | -7.98% |
| Dec 31, 2022 | 163 | 27 | 19.85% |
| Dec 31, 2021 | 136 | 41 | 43.16% |
| Dec 31, 2020 | 95 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Health Catalyst | 1,300 |
| Pacific Biosciences of California | 796 |
| Nano-X Imaging | 164 |
| Voyager Therapeutics | 162 |
| Absci | 155 |
| Kyverna Therapeutics | 96 |
| Aura Biosciences | 89 |
| Ocugen | 65 |
NKTX News
- 6 days ago - Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President - GlobeNewsWire
- 25 days ago - Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications - GlobeNewsWire
- 5 weeks ago - Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors - GlobeNewsWire
- 2 months ago - Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 3 months ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors - Business Wire
- 3 months ago - INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors - Business Wire
- 3 months ago - The Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors - Business Wire
- 3 months ago - Nkarta to Participate in Upcoming Investor Conferences - GlobeNewsWire